The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)

Viewpoint suggests immunity licenses should not be evaluated against baseline of normalcy, i.e. uninfected free movement, but against alternatives of enforcing strict public health restrictions for many months or permitting activities that could spread infection.

SPS commentary:

A second viewpoint warns that the ideal of a measured, evidence-based approach to policy making appears likely to be overrun by hopes and demands for antibody testing, which raises a host of important legal, ethical, and policy concerns that will not wait for greater scientific certainty.


Journal of the American Medical Association

Resource links:

Viewpoint 2